๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

24 recruiting trials

for Advanced High-Grade Epithelial Ovarian Cancer

Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer NCT07125391Phase 21 site๐Ÿ“ Hefei Bai-Rong Xia ยท Tests: Propranolol Hydrochloride, Paclitaxel liposome, Carboplatin A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003). NCT06843447Phase 1, Phase 239 sites๐Ÿ“ New Haven๐Ÿ“ Louisville๐Ÿ“ Shreveport Merck Sharp & Dohme LLC ยท Tests: Raludotatug Deruxtecan, Carboplatin, Paclitaxel, Bevacizumab, Rescue Medication Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers NCT06906341Phase 249 sites๐Ÿ“ Birmingham๐Ÿ“ Palo Alto๐Ÿ“ San Francisco Corcept Therapeutics ยท Tests: Relacorilant 150 mg once daily (QD), Nab-paclitaxel 80 mg/m^2, Bevacizumab 10 mg/kg Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer NCT05009082Phase 365 sites๐Ÿ“ Amberg๐Ÿ“ Augsburg๐Ÿ“ Bad Homburg AGO Study Group ยท Tests: Carboplatin, Paclitaxel, Bevacizumab, Niraparib IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors NCT05985655Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ New York Exscientia AI Ltd., a wholly owned subsidiary of Recursion โ€ฆ ยท Tests: GTAEXS617, SoC A Study of Radspherinยฎ in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery NCT06504147Phase 210 sites๐Ÿ“ Tampa๐Ÿ“ Leuven๐Ÿ“ Roma Oncoinvent Solutions AS ยท Tests: Radspherin A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites๐Ÿ“ Denver๐Ÿ“ Sarasota๐Ÿ“ Detroit IDEAYA Biosciences ยท Tests: IDE034 Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer NCT07371104Phase 11 site๐Ÿ“ Seoul Daewoong Pharmaceutical Co. LTD. ยท Tests: DWZ2501 (Olaparib 150mg), DWC202510 (Olaparib 150mg) A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy NCT05460000Phase 250 sites๐Ÿ“ Innsbruck๐Ÿ“ Brussels๐Ÿ“ Ghent North Eastern German Society of Gynaecological Oncology ยท Tests: 3 cycles chemotherapy instead of 6 cycles chemotherapy, 6 cycles chemotherapy Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer NCT06404671NA1 site๐Ÿ“ Alexandria Alexandria University ยท Tests: Delayed interval cytoreductive surgery (DICS), Early interval cytoreductive surgery (EICS) A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988Phase 1, Phase 214 sites๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach๐Ÿ“ Aurora Volastra Therapeutics, Inc. ยท Tests: VLS-1488 A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) NCT07743164Phase 34 sites๐Ÿ“ Fountain Valley๐Ÿ“ Orlando๐Ÿ“ Tel Aviv Merck Sharp & Dohme LLC ยท Tests: R-DXd, Bevacizumab, Carboplatin, Paclitaxel, Gemcitabine Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Genmab ยท Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine NCT06682988Phase 252 sites๐Ÿ“ Sarasota๐Ÿ“ Edgewood๐Ÿ“ Lexington AbbVie ยท Tests: Mirvetuximab Soravtansine A Study of Sovilnesib in Subjects With Ovarian Cancer NCT06084416Phase 111 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ Newport Beach Volastra Therapeutics, Inc. ยท Tests: Sovilnesib Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 NCT06084481Phase 154 sites๐Ÿ“ Duarte๐Ÿ“ San Francisco๐Ÿ“ Aurora AbbVie ยท Tests: ABBV-400, Itraconazole (ITZ), Bevacizumab Folate Receptor Alpha Dendritic Cells (FRฮฑDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial NCT06639074Phase 23 sites๐Ÿ“ Scottsdale๐Ÿ“ Jacksonville๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorโ€ฆ This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors NCT06451497Phase 13 sites๐Ÿ“ Boston๐Ÿ“ Austin, TX 78758๐Ÿ“ San Antonio Zumutor Biologics Inc. ยท Tests: ZM008 A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632Phase 1158 sites๐Ÿ“ Anchorage๐Ÿ“ Fayetteville๐Ÿ“ Rogers Seagen, a wholly owned subsidiary of Pfizer ยท Tests: sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT07665515Phase 110 sites๐Ÿ“ Cambridge๐Ÿ“ Edinburgh๐Ÿ“ Glasgow Epitopea Ltd ยท Tests: CryptiVax-1001 A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: EB-SELECT Single-Target CAR-NK Cells, Dual-Target Antigen-Selected CAR-NK First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer NCT06799065Phase 1, Phase 211 sites๐Ÿ“ Aurora๐Ÿ“ Sarasota๐Ÿ“ Detroit Accent Therapeutics ยท Tests: ATX-295, ATX-295 and bevacizumab (or biosimilar)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy